These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26875064)

  • 21. New Frontiers in Osteoporosis Therapy.
    Cheng C; Wentworth K; Shoback DM
    Annu Rev Med; 2020 Jan; 71():277-288. PubMed ID: 31509477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of aromatase inhibitors on bone metabolism].
    Folkestad L; Bjerregaard JK; Bjarnason NH; Brixen KT
    Ugeskr Laeger; 2007 May; 169(19):1774-9. PubMed ID: 17537350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal Osteoporosis: A Clinical Review.
    Watts NB
    J Womens Health (Larchmt); 2018 Sep; 27(9):1093-1096. PubMed ID: 29583083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial.
    Dimai HP; Ljuhar R; Ljuhar D; Norman B; Nehrer S; Kurth A; Fahrleitner-Pammer A
    Skeletal Radiol; 2019 Jul; 48(7):1023-1032. PubMed ID: 30506302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe low turnover osteoporosis.
    Pietrogrande L
    Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):26-9. PubMed ID: 18182889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis.
    Lewiecki EM
    J Clin Densitom; 2008; 11(4):478-84. PubMed ID: 18757222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug holidays in women treated for postmenopausal osteoporosis.
    McClung MR
    Menopause; 2018 Oct; 25(10):1152-1154. PubMed ID: 30044265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of herbal medicine BHH10 in postmenopausal women with osteoporosis: study protocol for a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial.
    Cho Y; Lee S; Kim J; Kang JW; Baek YH; Seo BK; Lee JD
    Trials; 2018 Sep; 19(1):482. PubMed ID: 30201024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Papapoulos S; Lippuner K; Roux C; Lin CJ; Kendler DL; Lewiecki EM; Brandi ML; Czerwiński E; Franek E; Lakatos P; Mautalen C; Minisola S; Reginster JY; Jensen S; Daizadeh NS; Wang A; Gavin M; Libanati C; Wagman RB; Bone HG
    Osteoporos Int; 2015 Dec; 26(12):2773-83. PubMed ID: 26202488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 33. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
    Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
    Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].
    Bartl R
    Dtsch Med Wochenschr; 2007 May; 132(18):995-9. PubMed ID: 17457784
    [No Abstract]   [Full Text] [Related]  

  • 35. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
    Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
    Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.
    Wu J; Zhang Q; Yan G; Jin X
    J Orthop Surg Res; 2018 Aug; 13(1):194. PubMed ID: 30071889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Would You Manage This Patient With Osteoporosis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Rosen H; Berry S; Smetana GW
    Ann Intern Med; 2018 Jun; 168(11):801-808. PubMed ID: 29868815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Ferrari S; Adachi JD; Lippuner K; Zapalowski C; Miller PD; Reginster JY; Törring O; Kendler DL; Daizadeh NS; Wang A; O'Malley CD; Wagman RB; Libanati C; Lewiecki EM
    Osteoporos Int; 2015 Dec; 26(12):2763-71. PubMed ID: 26068295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Osteoporosis.
    Cotts KG; Cifu AS
    JAMA; 2018 Mar; 319(10):1040-1041. PubMed ID: 29536084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.